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Abstract
Background: Missing data is a common phenomenon with survey-based research; patterns of missing data may
elucidate why participants decline to answer certain questions.
Objective: To describe patterns of missing data in the Pediatric Quality of Life and Evaluation of Symptoms
Technology (PediQUEST) study, and highlight challenges in asking sensitive research questions.
Design: Cross-sectional, survey-based study embedded within a randomized controlled trial.
Setting: Three large children’s hospitals: Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
(DF/BCCDC); Children’s Hospital of Philadelphia (CHOP); and Seattle Children’s Hospital (SCH).
Measurements: At the time of their child’s enrollment, parents completed the Survey about Caring for Children
with Cancer (SCCC), including demographics, perceptions of prognosis, treatment goals, quality of life, and
psychological distress.
Results: Eighty-six of 104 parents completed surveys (83% response). The proportion of missing data varied by
question type. While 14 parents (16%) left demographic fields blank, over half (n=48; 56%) declined to answer at
least one question about their child’s prognosis, especially life expectancy. The presence of missing data was unrelated
to the child’s diagnosis, time from progression, time to death, or parent distress ( p>0.3 for each). Written explanations
in survey margins suggested that addressing a child’s life expectancy is particularly challenging for parents.
Conclusions and Relevance: Parents of children with cancer commonly refrain from answering questions about
their child’s prognosis, however, they may be more likely to address general cure likelihood than explicit life
expectancy. Understanding acceptability of sensitive questions in survey-based research will foster higher
quality palliative care research.
Introduction
Parents of children with advanced cancer have highlevels of distress,1 not only because cancer poses a threat
to their child’s life, but also because they may feel a sense of
failed obligation to protect their child.2 Parent–physician
concordance regarding prognosis is generally poor3,4; this
lack of agreement may affect patients’ quality of life and
quality of death.4 Understanding parents’ perspectives about
their child’s prognosis and the barriers they face in articu-
lating them may lead to improved concordance, and in turn,
improved outcomes.
The Pediatric Quality of Life and Evaluation of Symptoms
Technology (PediQUEST) Study was a randomized controlled
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trial of a supportive care intervention in children with ad-
vanced cancer.5 Additional aims were to evaluate factors of
parent–provider concordance regarding prognostic awareness
and goals of care. However, we found a high proportion of
missing data when parents were asked to describe their child’s
prognosis. The objectives of this brief report are to describe
patterns of our missing data and highlight challenges in asking
sensitive questions while conducting research among parents
of children with serious illness.
Methods
Eligible patients were at least 2 years old, had at least a 2-
week history of progressive, recurrent, or refractory cancer,
and had received cancer therapy at Dana-Farber/Boston
Children’s Cancer and Blood Disorders Center (DF/
BCCDC); Children’s Hospital of Philadelphia (CHOP); or
Seattle Children’s Hospital (SCH). Their parents/legal
guardians had written command of the English language. All
parents/patients over 17 years of age provided informed
consent for participation. The Institutional Review Board at
each participating institution approved the study.
Consecutive eligible families were approached and 104
children enrolled between December 2004 and June 2009. At
the time of enrollment, all parents were invited to complete
the Survey about Caring for Children with Cancer (SCCC).
This comprehensive paper-and-pencil, self-administered
survey evaluates perceptions of the child’s illness. Devel-
opment has been previously described1,4,6 using focus groups
and interviews with parents of children with advanced can-
cer, and then pretested for content, response-burden, and
cognitive validity. Domains evaluated in the SCCC include:
1) Sociodemographics
2) Prognosis and treatment goals: 32 items query parent
perceptions of prognosis, life expectancy, and treat-
ment goals at the time of cancer diagnosis and upon
enrollment. Regarding prognosis, parents are asked:
(a) ‘‘How likely it is that your child will be cured?’’
(response options: ‘‘very likely’’/‘‘likely’’/‘‘un-
likely’’/‘‘very unlikely’’); and,
(b) ‘‘What is your understanding of how long your
child will live?’’ (response options: ‘‘days to
weeks’’/‘‘weeks to months’’/‘‘months to years’’/
‘‘several years’’/‘‘normal life expectancy’’). Par-
ents are also asked to select a primary treatment
goal: ‘‘to cure your child’s cancer,’’ ‘‘to be able to
keep hoping,’’ ‘‘to make sure you have done ev-
erything,’’ ‘‘to extend your child’s life as long as
possible without expecting a cure,’’ ‘‘to lessen
suffering,’’ and ‘‘to help cancer research.’’.
3) Child quality of life: 6 items explore parent percep-
tions of the child’s emotional and physical health-
related quality of life in the preceding month.
4) Parent psychological distress: Measured with the
Kessler 6-item General Psychological Distress Scale
(K6).7
Individual responses were defined as ‘‘missing’’ when
parents left an item blank (no response provided) or ambig-
uous (more than one response provided). Several parents
provided written explanations when omitting a response;
these were transcribed verbatim for further analysis. We
quantified the prevalence of ‘‘missingness’’ by SCCC do-
main and analyzed the qualitative answers provided.
Enrolled patient’s clinical information was extracted from
medical records and included cancer type, age, date of diag-
nosis, dates of first and subsequent disease progression, and,
where relevant, date of death. We categorized patients with
‘‘recent’’ progressive disease if they had documented pro-
gression within 100 days prior to enrollment. Patients who
died within 100 days after enrollment were categorized as
having ‘‘early’’ death, and all who died within a 3-year period of
follow-up were coded as having ‘‘eventual’’ death. Descriptive
statistics were used to characterize all variables. In order to
compare parents with and without missing responses, we used
v2 and Fisher’s exact tests to evaluate associations with child
cancer type, progressive disease, and death, and Student’s t tests
with unequal variance to evaluate the association with average
parent distress scores. All analyses were performed with Stata
12.1 statistical software (StataCorp, College Station, TX).
Results
Eighty-six of 104 enrolled parents completed the SCCC
(83% response). Parent and child demographics were similar
among those who did and did not complete the survey. Most
were white mothers with at least a college education and
annual household incomes above $75,000 (Table 1). Most
parents left at least one item of the SCCC unanswered (Table
2). Fourteen (16%) left individual demographic items blank,
most commonly their annual income. By comparison, over
half did not complete all items regarding child prognosis and
treatment goals. Parents were less likely to respond to ques-
tions about life expectancy than overall cure likelihood.
Specifically, 15 (17%) and 26 (30%) parents did not provide
an answer to items regarding life expectancy at diagnosis or
‘‘now,’’ respectively. Eleven (13%) left both questions blank.
Fewer parents, 4 (5%) and 12 (14%), respectively, declined to
answer questions of cure likelihood, with only one parent
leaving both items blank. Most parents reported their goals of
therapy at the time of diagnoses, but 15 (17%) did not provide
current goals. The majority (n= 81, 94%) completed the
psychological distress subscale.
There were no differences in average psychological dis-
tress scores among those who did and did not respond to
prognosis questions ( p = 0.9). Likewise, there were no strong
associations between missing cure-likelihood, life expec-
tancy, and treatment goal answers with either child cancer
type ( p = 0.3–0.9), recent progressive disease ( p = 0.3–0.6),
early ( p = 0.1–0.3), or eventual death ( p = 0.2–0.9).
Parents’ qualitative comments regarding their child’s
current life expectancy suggested that this item was per-
ceived distinctly from others in the questionnaire, not only
because they provided explanation for their lack of item-
response, but also because their comments reflected relative
uncertainty (Table 3).
Discussion
Our objectives were to underscore what we can learn from
patterns of missing data. We found that parents of children
with advanced cancer are less likely to respond to research
questions regarding their child’s prognosis, particularly cur-
rent life expectancy, compared with other types of questions,
including those regarding race, income, or quality of life.
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Those who leave questions blank do not appear to be more (or
less) distressed than other parents, nor is their lack of re-
sponse related to their child’s overall condition. Rather,
written comments suggest an unwillingness or inability to
explicitly document an expected duration of life.
These results are limited in that they represent a cross-
sectional sample of parents with narrow diversity (mostly
white mothers with higher education). We were unable to
assess how racial and cultural perspectives might play into
willingness to articulate a child’s prognosis. Finally, we only
determined ‘‘missingness’’ within the sample of parents who
returned their larger study surveys, and thus cannot gener-
alize to the 17% of nonresponding parents.
Missing data in survey research is a common and expected
phenomenon,8 and there are established methods for handling
item nonresponse.9,10 Unfortunately, these methods are un-
able to address why individual survey items are omitted;
instead, we are left to make reasonable speculations. For
example, we did not identify an association between ‘‘early’’
patient death and missing parent response. This may be due to
limited power, but reasons for missingness are likely more
complex and subjective. Perhaps what parents publicly ac-
knowledge is different from what they privately think. Per-
haps formally accepting the possibility of death of one’s child
is akin to ‘‘giving up’’ and undermines parental identity.11
Perhaps responding in writing (and committing) to research
questions regarding prognosis is associated with superstition
(‘‘if I say it, will it come true’’).
Most parents of children with cancer acknowledge that
hearing their child’s prognosis is a distressing but necessary
element of their medical care.12 While the majority of those
who participate in research regarding prognosis report that it
Table 2. Prevalence of Missing Responses
in Selected SCCC items (n= 86)
Total number of
parents who left
unanswered
or ambiguous
item response (%)a
Parent sociodemographics 14 (16)
Age 1 (1)
Gender 0 (0)
Ethnicity or race 5 (6)
Education 0 (0)
Income 8 (9)
Prognosis and treatment goals 48 (56)
Likelihood of cure (at diagnosis) 4 (5)
Likelihood of cure (currently) 12 (14)
Life expectancy (at diagnosis) 15 (17)
Life expectancy (currently) 26 (30)
Treatment goals (at diagnosis) 3 (3)
Treatment goals (currently) 15 (17)
Parent report of child quality of life 9 (11)
Psychological symptoms 7 (8)
Physical symptoms 3 (3)
Parent psychological distress 5 (6)
aMissing items defined as any item left blank or with ambiguous
answer.
SCCC, Survey about Caring for Children with Cancer.
Table 1. Parent and Child Demographic
Characteristics (n= 86)
Parents n (%)
Gender
Female 74 (86)
Male 12 (14)
Ethnicity (n = 85)
Non-Hispanic/Latino 77 (93)
Hispanic/Latino 6 (7)
Race (n = 82)
White 76 (93)
African American 3 (4)
Asian 1 (1)
Othera 2 (2)
Education
High school or less 28 (33)
College 45 (52)
Graduate school or professional degree 13 (15)
Annual family income (before taxes) (n = 78)
< $25,000 11 (14)
$25,000–$49,999 11 (14)
$50,000–$74,999 16 (21)
‡ $75,000 40 (51)
Mean age (SD): 43.6 years (7.5)
Children n (%)
Gender
Female 46 (53)
Male 40 (47)
Diagnosis
Hematologic malignancy 28 (33)
Non-CNS solid tumor 49 (57)
CNS tumor 9 (10)
Progressive disease within
100 days prior to enrollment
29 (34)
‘‘Early’’ death (within 100 days
after enrollment)
8 (9)
‘‘Eventual’’ death (at any time
following study enrollment)
40 (47)
Mean age (SD): 12.1 years (5.8)
aWrite-in race responses: ‘‘Hispanic,’’ and ‘‘Peruvian.’’
CNS, central nervous system; IQR, interquartile range; SD,
standard deviation.
Table 3. Examples of Parent’s Written
Explanations for Leaving Formal Responses Blank
SCCC question Parent responses
‘‘What is your
understanding now
of how long your
child will live?’’
‘‘Don’t know, day to day,
I really don’t get into this—
What good does this do anyway?’’
‘‘No one can answer this question.’’
‘‘50% cure rate if bone marrow
was possible and without
treatment maybe 1 year.’’
‘‘Doctors cannot be sure.there
is no way to know for sure.
It depends on what we do next.’’
‘‘Don’t know yet.’’
SCCC, Survey about Caring for Children with Cancer.
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is at least ‘‘a little’’ useful to them, the odds that they will
experience distress are over five times higher when the
prognostic information is upsetting.13 Furthermore, parents
of children at the end of life want ‘‘what is best for their
child,’’14,15 but often request continued cancer-directed
therapy even when there is no chance of cure.16,17 They tend
to acknowledge their child’s impending death 100 days later
than their health care providers.4 Meanwhile, health care
providers may struggle with what they perceive as unrealistic
parent expectations18 or futile treatments.
Understanding and resolving these conundrums is one of
the objectives of pediatric palliative care research, and many
studies rely on surveys to identify parent perspectives. We
pretested the SCCC and found no evidence of parent re-
sponse-burden or concern with individual items. Still, our
findings suggest that parents selectively choose not to answer
certain types of questions and that there are legitimate ex-
planations for their omissions. Future qualitative investiga-
tions may focus on why certain data are commonly missing,
and continued research may address which questions inves-
tigators should (and should not) ask. Doing so will help us
better understand the parent experience in survey research,
and incorporate methodological modifications to ensure
higher quality research.
Conclusion
Parents of children with cancer commonly refrain from
answering questions about their child’s prognosis. Under-
standing the patterns of missing data will enable higher
quality research which, in turn, may enable improved parent,
patient, and whole-family care.
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